253 related articles for article (PubMed ID: 37593952)
1. Gut microbiome and its clinical implications: exploring the key players in human health.
Koneru S; Thiruvadi V; Ramesh M
Curr Opin Infect Dis; 2023 Oct; 36(5):353-359. PubMed ID: 37593952
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation: Emerging applications in autoimmune diseases.
Yang R; Chen Z; Cai J
J Autoimmun; 2023 Dec; 141():103038. PubMed ID: 37117118
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiome (Bacteria, Fungi, and Viruses) and HIV Infection: Revealing Novel Treatment Strategies.
Ma J; Wen S; Dong A; Fan W; Kang Y
Mol Nutr Food Res; 2023 Dec; 67(23):e2300566. PubMed ID: 37867202
[TBL] [Abstract][Full Text] [Related]
4. The role of microbiome-based therapeutics for the reduction and prevention of antimicrobial-resistant organism colonization.
Mansoor AE; O'Neil CA; Kwon JH
Anaerobe; 2023 Oct; 83():102772. PubMed ID: 37572864
[TBL] [Abstract][Full Text] [Related]
5. Possibilities of therapeutic manipulation of the gut microbiota.
Drastich P; Bajer L; Kverka M
Vnitr Lek; 2018; 64(6):665-671. PubMed ID: 30223665
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases.
Han Z; Min Y; Pang K; Wu D
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958637
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
8. Microbiomes in physiology: insights into 21st-century global medical challenges.
Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
Haak BW; Prescott HC; Wiersinga WJ
Front Immunol; 2018; 9():2042. PubMed ID: 30250472
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota: a target for intervention in obesity.
Sehgal K; Khanna S
Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
[TBL] [Abstract][Full Text] [Related]
11. The gut microbiota and gut disease.
Fehily SR; Basnayake C; Wright EK; Kamm MA
Intern Med J; 2021 Oct; 51(10):1594-1604. PubMed ID: 34664371
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood.
Eindor-Abarbanel A; Healey GR; Jacobson K
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830388
[TBL] [Abstract][Full Text] [Related]
13. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
Elangovan A; Allegretti JR; Fischer M
Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
[No Abstract] [Full Text] [Related]
14. Translating Microbiome Research From and To the Clinic.
Zhang ZJ; Lehmann CJ; Cole CG; Pamer EG
Annu Rev Microbiol; 2022 Sep; 76():435-460. PubMed ID: 35655344
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota modulation: a tool for the management of colorectal cancer.
Wang Y; Li H
J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Gut Microbiome to Treat Cardiometabolic Disease.
Theofilis P; Vlachakis PK; Oikonomou E; Tsioufis K; Tousoulis D
Curr Atheroscler Rep; 2024 Feb; 26(2):25-34. PubMed ID: 38180642
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
[TBL] [Abstract][Full Text] [Related]
18. The Role of Fecal Microbiota Transplantation in the Treatment of Neurodegenerative Diseases: A Review.
Matheson JT; Holsinger RMD
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674517
[TBL] [Abstract][Full Text] [Related]
19. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
Carlucci C; Petrof EO; Allen-Vercoe E
EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396
[TBL] [Abstract][Full Text] [Related]
20. Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics.
Porcari S; Fusco W; Spivak I; Fiorani M; Gasbarrini A; Elinav E; Cammarota G; Ianiro G
Lancet Gastroenterol Hepatol; 2024 May; 9(5):460-475. PubMed ID: 38604200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
